Thyroid hormone (tri-iodo-thyronine, T 3 ) exerts transcriptional effects on target genes in responsive cells. These effects are determined by DNA/protein interactions governed by the type of T 3 receptors (TRs) in the cell. As TRs show tissue and developmental variations, regulation is best addressed in an integrated in vivo model. We examined TR subtype effects on thyrotropin-releasing hormone (TRH) transcription and on the pituitary/thyroid axis end point: thyroid hormone secretion. Polyethylenimine served to transfect a TRH-luciferase construct containing 554 bp of the rat TRH promoter into the hypothalami of newborn mice. Transcription from the TRH promoter was regulated in a physiologically faithful manner, being significantly increased in hypothyroidism and decreased in T 3 -treated animals. Moreover, when various ligand binding forms of mouse or chicken TRb and TRa were expressed with TRH-luciferase, all forms of TRb gave T 3 -dependent regulation of TRH transcription, whereas transcription was T 3 insensitive with each TRa tested. Moreover, chicken TRa increased TRH transcription sixfold, whereas mouse TRa decreased transcription. These transcriptional effects had correlated physiological consequences: expression of the chicken TRa in the hypothalamus of newborn mice raised circulating T 4 levels by fourfold, whereas mouse TRa had opposite effects. Thus, TR subtypes have distinct, physiologically relevant effects on TRH transcription.-Guissouma, H., Ghorbel, M. T., Seugnet, I., Ouatas, T., Demeneix, B. A. Physiological regulation of hypothalamic TRH transcription in vivo is T 3 receptor isoform specific. FASEB J. 12, 1755-1764 (1998) Key Words: nonviral gene transfer · polyethylenimine · thyroid hormone · mouse · central nervous system A CENTRAL PROBLEM in understanding endocrine control of transcription is how stage-specific and cellspecific responses arise from ubiquitous signals. In the case of thyroid hormone (tri-iodo-thyronine, T 3 ) 2 -induced responses, current thinking identifies a number of key players. These include three differentially expressed T 3 binding receptor (TR) isoforms-TRa1, TRb1, and TRb2-produced from two TR genes, also called c-erbAa and c-erbAb (1). In combination with their heterodimeric partners, these TRs may determine recognition of different core motifs (thyroid response elements, TREs). Further complexity is brought about by interactions between receptors and other transcription factors either directly or through coactivator or corepressor proteins (for reviews, see refs 2, 3).
A CENTRAL PROBLEM in understanding endocrine control of transcription is how stage-specific and cellspecific responses arise from ubiquitous signals. In the case of thyroid hormone (tri-iodo-thyronine, T 3 ) 2 -induced responses, current thinking identifies a number of key players. These include three differentially expressed T 3 binding receptor (TR) isoforms-TRa1, TRb1, and TRb2-produced from two TR genes, also called c-erbAa and c-erbAb (1) . In combination with their heterodimeric partners, these TRs may determine recognition of different core motifs (thyroid response elements, TREs). Further complexity is brought about by interactions between receptors and other transcription factors either directly or through coactivator or corepressor proteins (for reviews, see refs 2, 3).
As these TR-dependent interactions will have cellspecific and developmentally dependent dimensions, we chose to analyze T 3 -dependent, cell-specific responses by following regulation of a key target gene, TRH (thyrotropin-releasing hormone), within the hypothalamus. Although this gene is expressed both within the hypothalamus and in extrahypothalamic brain areas (4), we chose to examine hypothalamic transcription because the hypothalamic neurons expressing TRH are responsible for controlling the hypothalamo/hypophysio/thyroid (HHT) axis and are most sensitive to negative feedback by T 3 (5) . Indeed, the model of TRH transcription has the advantage of showing clear-cut responses that allow the contribution of different players to be dissected. In particular, the specific role of TRb in mediating T 3 -dependent regulation of this gene has been addressed in primary hypothalamic neuronal cultures (6) and in cell lines (7) (8) (9) .
The distinct effects of TR subtypes on neuronal TRH transcription seen in chick hypothalamic cultures (6) reflect the spatial expression patterns of TRs in the chick (10, 11) and rat brain (12) , with particularly high levels of expression of TRb in the hypothalamus. To take the physiological analysis a step further, into an in vivo context, we used the newborn mouse. In this model, not only could we examine TR subtype effects on TRH promoter activity in the hypothalamus in situ, but also the end point of the HHT axis output, namely, circulating thyroid hormones.
Only in vivo models can be used for this type of study. Modulation of TR status can be achieved in vivo by germinal transgenosis or somatic gene transfer. Transgenic mice have been generated that are homozygous for targeted inactivation of either the TRa (13) or the TRb genes (14) . These powerful approaches have shown differential effects of TR subtypes, producing distinct phenotypes. However, eliminating gene expression from the begining of development will affect processes downstream of early TR action. So to analyze TR effects at a defined, physiologically relevant moment, somatic gene transfer can have its advantages. Moreover, such methods allow one to study physiological responses in both genetically intact animals and modified genetic backgrounds.
Synthetic gene transfer methods, and polyethylenimine (PEI) in particular, can be adapted to these ends (15) . By using PEI-based gene transfer in the hypothalamus, we show that all TRb isoforms tested mediated T 3 -dependent inhibition of transcription from the TRH promoter, whereas ligand binding TRa isoforms did not provide T 3 -dependent inhibition. Moreover, introducing chicken TRa or mouse TRa into the hypothalamus respectively increased or decreased basal TRH-luc transcription, and these transcriptional effects were correlated with changes in circulating T 4 . In contrast, expressing TRb, the TR subtype most represented in the hypothalamus, did not disturb HHT equilibrium. These results bolster the hypothesis that TR subtypes have distinct transactivating properties that hold physiological relevance.
MATERIALS AND METHODS

Plasmids
Plasmids were prepared by using Jetstar columns (Bioprobe Systems, Paris, France), suspended in Tris-HCl 10 mM, EDTA 1 mM pH 8, and stocked as aliquots at 02ЊC.
TheTRH-LUC construct contains a rat TRH gene 5 fragment (16) extending from 0554 to /84 base pairs cloned upstream of the firefly luciferase-coding region (17) .
The TREpal-LUC construct contains a synthetic oligodeoxynucleotide sequence encoding a palindromic TRE in SV-luciferase (18) . The CMV-LUC expression vector was from Promega, Madison, Wis. The pCMVb-gal plasmid was from Clontech (Palo Alto, Calif.). Plasmids expressing mouse (m) TRa1, mTRb1, and mTRb2 receptors were generously provided by Dr. W. Wood (University of Colorado). Each cDNA is in pRSVL (19) vector, with the Roux sarcoma virus (RSV) promoter. A plasmid expressing full-length wild-type chicken TRa1 (c)TRa1 was generously provided by Dr. H. H. Samuels (New York University Medical Center). This vector has the RSV promoter in pEXPRESS vector (20) . The cTRb2 used was pSG5-TRb2 (11).
Treatment of animals: production of hypothyroid newborn mice
Female OF1 mice (Iffa Credo, l'Abresle, France) were mated. To induce fetal and neonatal hypothyroidism, dams were given 0.05% 6-n-propyl-2-thiouracil (PTU) in drinking water at day 14 of pregnancy. PTU administration was continued throughout the lactation period. For evaluating T 3 effects on TRH mRNA levels or transcription, hypothyroid or normal pups were injected with 250 mg of T 3 /100 g of body weight (in 9‰ saline). Controls received saline (9‰) injections.
Preparation of PEI/DNA complexes
DNA was diluted in 5% glucose. After vortexing, 25 kDa PEI (Sigma, France) was added (nine equivalents, PEI amine/ DNA phosphate) and the solution was revortexed. The required amount of PEI, according to DNA concentration and number of equivalents needed, is calculated by taking into account that 1 mg DNA is 3 nmol of phosphate and that 1 ml 0.1 M PEI is 100 nmol of amine nitrogen.
In vivo gene transfer
Pups were injected on postnatal day 1 (P1). Pups were anesthetized by hypothermia on ice. The pups heads were held by hand and a small incision was made with iris scissors through the skin overlying the sagittal suture to expose the skull. A small hole was made through the skull approximately 1 mm lateral to the sagittal suture. A glass micropipette was lowered 2 mm through the incision and 2 ml of a 5% glucose solution containing plasmid/PEI complexes was slowly injected bilaterally into the hypothalamus. Pups were kept under an infrared heat lamp until active.
After 18 h, mice were anesthetized and decapitated. Hypothalami were dissected out for luciferase analyzes or nuclear receptor extraction. Animals treated with T 3 received subcutaneous injections immediately after gene transfer. Controls received saline at the same time point.
Luciferase assay
Hypothalami were homogenized in 150 ml assay buffer, then luciferase assay was performed according to the standard protocol (luciferase assay system, Promega) in a single-well luminometer (ILA911, MGM Instruments, Hamden, Conn.). Luciferase was estimated during 10 s with 20 ml brain extract. Light was expressed as relative light units (RLU).
LacZ histochemistry
Pups were decapitated 24 h after transfection and brains were dissected out. In toto LacZ histochemistry was performed as described (21) and vibratome sections (100 mm) were prepared.
Nuclear receptor extraction
Pools of hypothalami from 12 P1 mice were used in each experiment. Hypothalami were removed, weighed, homogenized at 2ЊC (0.25 weight/volume) in 250 mM sucrose, 2 M MgCl 2 , 20 M Tris-HCl (pH 7.6) using a glass-teflon homogenizer, and filtered through nylon Bultex 48 mm. Filtrates were centrifuged (15001g, 10 min). Pellets were / 383c de15 Mp 1757 Thursday Oct 22 08:58 AM LP-FASEB de15 washed twice in the homogenizing buffer supplemented with 0.5% triton X-100 and centrifuged (15001g, 10 min). Pellets were resuspended in binding buffer, rehomogenized (50 mM NaCl, 10% glycerol, 2 mM EDTA, 5 M 2-mercaptoethanol, 20 mM tris-HCl, pH 7.6), and centrifuged (15001g, 10 min). This operation was repeated three times. The final pellets were resuspended in 3 ml of 0.4 M KCl, 1 mM MgCl 2 , 20 mM tris-HCl (pH 7.9), stored for 30 min on ice, and centrifuged at 35,0001g for 30 min. Supernatants were dialyzed three times in binding buffer and centrifuged (50001g, 20 min). Fifty microliters of the supernatants were used to dose protein content with a commercial kit (Bio-Rad, Richmond, Calif.).
T 3 binding assay
Samples (350 ml) of nuclear receptor extracts were incubated with [
125 I]T 3 (2.6 nM, specific activity ú1200 mCi/ mg; Amersham, Buckinghamshire England) for 45 min at 25ЊC. After incubation, 3.5 ml binding buffer were added to each sample, then solutions were filtered at 2ЊC under vacuum through 0.45 mm Millipore nitrocellulose (HAWP) filters in order to separate bound and free [
125 I]T 3 . Filters were washed with 3 1 5 ml binding buffer. Radioactivity was measured in a gamma counter. Nonspecific binding (NSB) was determined in samples containing the tracer and an excess of (2.6 mM) stable T 3 . NSB was substracted from total binding to calculate the specific binding.
Radioimmunoassay of T 4 and T 3 hormones
Radioimmunoassay of plasmatic T 4 and T 3 hormones was carried out as previously described (22) .
PCR analysis
Hypothalami of mice transfected with a given TR vector were homogenized in 150 ml luciferase buffer and centrifuged (10 min, 12,0001g). Phenol/chloroform extraction was carried out on 120 ml supernatant. After sodium acetate (3 M) precipitation, DNA was resuspended in TE buffer, pH8 (TE is 10 mM Tris-HCl, 1 mM EDTA).
Polymerase chain reaction (PCR) amplifications were performed in a final volume of 50 ml containing 11 reaction buffer, 5 ml template DNA, 2 mM of primers, 200 mM deoxynucleotides (dATP, dCTP, dGTP, dTTP), and 1 unit of Taq polymerase. The following primers were used to detect ampicillin cDNA sequence present in all the plasmids used in our experiments: sense, 5-CCAATGCTTAATCAGTGAGGCACC-3; antisense, 5-ATTCAACATTTCCGTGTCGCCC-3. Internal controls were run on the same samples using mouse bactin primers: sense, 5-GCTGAGAGGGAAATCGTGCG-3; antisense, 5-CCAGGGAGGAAGAGGATGCG-3. Amplification occurred during 40 cycles (1 min, 94ЊC; 1 min, 60ЊC; and 1 min, 72ЊC). PCR products were separated on 2.8% agarose gels containing 0.1 mg/ml ethidium bromide.
Statistical analysis of results
In vivo gene transfer results are expressed as means { SEM per group. Student's t test was used to analyze differences between groups. Where appropriate, one-way analysis of variance (ANOVA) with post hoc multiple comparison analysis by the Bonferroni test for independent variables was applied. Differences were considered significant at P õ 0.05. In all cases typical experiments are shown, each experiment having been repeated at least three times and providing the same result.
RESULTS
PEI/DNA complex injection into the hypothalamus
We first ensured that PEI/DNA injection resulted in transgene expression within the hypothalamus. Figure 1A shows a section of a newborn mouse brain transfected with CMVb-gal. Transgene expression was seen around the third ventricule in numerous neuron-like cells. Expression was also found in some other sites close to ventricular spaces, such as regions of the hippocampus closely bordering the lateral ventricles (Fig. 1B) . This is to be expected as complexes reaching the third ventricule will diffuse through the ventricules to other brain areas (21) . We quantified transgene distribution by comparing levels ofCMV-luc expression in the hypothalamus and extrahypothalamic tissue. Luciferase was detected within the hypothalamus, but also in the cortex, striatum, and hippocampus (Fig. 1C) . Generally, levels were lower in the extrahypothalamic areas, but differences were not significant. This was in sharp contrast to the result obtained with TRH-luc. As shown in Fig. 1D , expression was fivefold higher in the hypothalamus than in any other region (Põ0.001) and, most important, only in the hypothalamus was transcription from this physiological promoter sensitive to T 3 treatment.
TRH-luciferase transcription in the hypothalamus is T 3 dependent and regulated in a physiologically meaningful manner
We next pursued the analysis of physiological regulation of transgenes in the hypothalamus. As seen in Fig. 2A , transcription from the TRH promoter was regulated in accordance with the thyroid status of the animals. In hypothyroid animals, the mean level of transcription from the TRH-luc construct (3.7{0.37 10 5 RLU/ hypothalamus, nÅ10) was twice that of normal animals (2.2{0.36 10 5 RLU/ hypothalamus, nÅ10,Põ0.05). Treating normal pups with 250 mg of T 3 /100 g body weight further decreased TRH promoter activity by half (1.1{0. 27 10 5 RLU/ hypothalamus, nÅ10, Põ0.05).
In contrast, expression of luciferase from a constitutive promoter (CMV) was unaffected by T 3 in the hypothalamus (Fig. 2B) .
Inter-and intraassay transfection variability
Intraassay variability in the transfection experiments was particularly low; SEMs were routinely°10% of the mean with n ¢10. This underlines the consistency of this gene transfer method in the hypothalamus. This low intraassay variability obviates the need to add a constitutively expressed gene to normalize for transfection efficiency as is often the case for most in vitro work and some in vivo work (23) . Interassay variability could be higher, with different plasmid preparations providing higher luciferase readings. However, the same physiological regulations are always observed whatever the basal level of expression (compare Fig.  2A and Fig. 3A) .
Only TRbs, and not TRa1, mediate T 3 -dependent regulation of TRH transcription
The effects of different T 3 binding TR isoforms on TRH promoter activity were examined next. We tested both chicken (c) and mouse (m) forms of TRa and TRb. As seen in Fig. 3A , cotransfecting a control plasmid containing the RSV promoter and no coding sequence had no effect on in vivo transcription from the TRH promoter, significant T 3 -dependent inhibition of transcription being found. When TRH-luc was expressed with ligand binding forms of mammalian or avian TR subtypes, there were clear-cut distinctions in TR activities.
First, both mTRa1 and cTRa1 abrogated the negative transcriptional effect of T 3 . Indeed, no statistical difference in TRH transcription was found in controls or T 3 -injected animals (Fig. 3B ) in which either TRa1 was expressed. Moreover, the effects of mTRa1 and cTRa1 on basal transcription were different, with mTRa1 halving basal TRH-luc transcription and cTRa increasing transcription by sixfold (Põ0.001 in each case).
Second, all forms of TRb isoforms mediated negative transcriptional effects of T 3 on TRH transcription equivalent to that seen in controls. For each TRb isoform tested (cTRb2, mTRb1, and mTRb2), statistically significant decreases in transcription were seen in T 3 -injected animals as compared to controls (Fig.  3C) . Again, as for the a subtypes, the TRb isoforms differentially affected basalTRH-luc transcription: cTRb2 decreased basal transcription by fivefold (Põ0.001), mTRb1 did not modify basal transcription, whereas mTRb2 decreased it by threefold (Põ0.001).
Both mTRa1 and mTRb2 activate transcription from a positive TRE-containing promoter in the hypothalamus
To determine whether these isoform effects were specific to the TRH promoter, we carried out transfection experiments with the same TRs and a positively regulated TRE-pal construct injected into the hypothalamus. No T 3 -dependent regulation could be revealed in normal animals (data not shown), probably because normal levels of T 3 maximally activated the promoter. However, in hypothyroid animals significant T 3 -dependent activation of TRE-transcription was seen, and this was equivalent for each TR isoform tested, whether from mice (Fig. 4) or chicken (data not shown).
Each TR isoform increases specific T 3 binding in the hypothalamus to an equivalent extent
To verify that differences in TR isoform effects on TRH transcription were not due to variations in the efficiency of expression and protein production, we carried out T 3 binding studies on hypothalamic nuclear extracts from control and transfected mice. As shown in Fig. 5 , we found that the [ 125 I]T 3 binding capacity of nuclear extracts prepared from animals transfected with any one of the TR constructs used was approximately 2.5 1 the capacity of control, nontransfected mice or mice transfected with an empty plasmid. Using ANOVA analysis, we found the values in TR transfected animals to be significantly higher (Põ0.05) from those in the two control groups. There were no differences in T 3 binding between TR groups.
Expression of mouse or chicken TRa in the hypothalamus modifies thyroid status
The end point of the HHT regulatory system is the secretion of thyroid hormone, principally T 4 in mammals (24) . To determine the effects of TR subtype expression within the hypothalamus on thyroid hormone secretion, we expressed various TRs and measured circulating T 4 and T 3 over the following week. As seen in amus resulted in a significant, nearly fourfold, increase in circulating T 4 at P4, whereas mTRa1 decreased serum T 4 at the same time point. Both these modifications were highly significant (Põ0.001 in each case). No changes in circulating T 4 were seen in controls (injected with RSV control plasmid) nor in animals transfected with equivalent amounts of mTRb1. In cTRa1-injected animals, circulating levels of T 4 returned to control levels by P6. This lack of cTRa1 effect at this time point was correlated with loss of plasmid from the hypothalamus. As seen in Fig. 7 , PCR showed plasmid to be present in the hypothalamus of transfected pups for up to P4, but not P6. Levels of T 3 , produced principally at the periphery by desiodation (24), were not significantly different in any group at any time point examined (data not shown).
DISCUSSION
Nonviral gene transfer into a defined brain area can be used to study gene regulation and transcription factor function
The first finding to arise from these studies is that PEI-based gene transfer into the brain provides physiologically coherent regulation from a promoter that 125 I]T 3 binding capacity of nuclear extracts of nontransfected (NT) mice hypothalami or hypothalami transfected with either control plasmid, cTRa1, mTRa1, cTRb2, mTRb1, or mTRb2. Mice were transfected at P1 into the hypothalamus with 150 ng of each plasmid. Animals were killed 18 h later. The hypothalami were dissected out, nuclear receptors were extracted, and binding studies were carried out as described in Material and Methods. Means { SEM are given, n Å 12 per point.
has region-specific expression and hormone-dependent regulation. Two key observations bolster this idea. First, there is a sharper differential in the expression of a physiological promoter from the site of injection to more distant sites into which the transgenes diffuse than for a constitutive, viral promoter (compare Fig. 1C, D) . Second, only the TRH-luc construct is regulated by T 3 and regulation is seen only in the hypothalamus (Fig. 1C) .
That low levels of transcription from the TRH promoter were found in each of the different brain regions dissected out (cortex and thalamus/stria-tum) fits with published data. First, pro-TRH mRNA is found in numerous extrahypothalamic sites (4); second, in transgenic mice expressing luciferase downstream from a sequence containing several hundred base pairs of the 5 region and exon 1 of the rat TRH gene, luciferase expression is found both in the forebrain and in the hindbrain (25) .
The finding that it is only in the hypothalamus that T 3 down-regulates transcription from TRH promoter corroborates data obtained by in situ hybridization in the adult rat brain by Koller et al. (5) . These authors showed that modulating thyroid status changed TRH mRNA production in the hypothalamus, but not in the thalamus. Thus, although injection into the hypothalamus results in diffusion of PEI/DNA into the third ventricle and from thence into other brain regions (21) , expression from the TRH promoter reflects endogenous gene expression and, most important, T 3 -dependent negative feedback occurs only in the hypothalamus. Moreover, feeding PTU to the dams rendered the pups hypothyroid (T 3 levels were undetectable in the pups, data not shown), and this treatment significantly raised TRH transcription. Thus, modulation of thyroid status resulted in transcription from the TRH-luc construct expressed in the hypothalamus that faithfully reflected that recorded for the endogenous gene followed by in situ hybridization (5).
The negative feedback effect of T 3 on TRH transcription is mediated by the b receptor
We next analyzed the differential effects of TR isoforms on transcription. Only TRbs, but not cTRa or mTRa, mediated T 3 -dependent inhibition of transcription in this in vivo context. These differential effects were not due to variations in TR expression, since each TR used produced equivalent increases in functional T 3 binding. This finding of differential effects of TRb vs. TRa in regulating TRH transcription agrees with previous data from our laboratory (6) obtained using the same TRH-luc in primary cultures of chick hypothalamic neurons. In this in vitro work, we tested cTRb and cTRa1, and observed that only cTRb down-regulated TRH transcription whereas both isoforms were equipotent on transcription from a TRE construct (6) . Similarly, it has been shown that human TRb1, but not TRa1, down-regulates transcription from the human TRH promoter in transient transfection assays in the CV-1 cell line (7) .
The specific action of TRb in regulating the TRH gene correlates well with the high expression of this receptor in the hypothalamus (12) . However, an additional level of complexity must be taken into account, the production of two isoforms from the cerbAb locus: TRb1 and TRb2 in rodents and humans (26, 27) , and TRb0 and TRb2 in chicken (11) . In mammals, it is the TRb2 isoform that has a particularly restricted expression, with the mRNA found almost exclusively in hypothalamus in the rat (28) . Recently, Langlois et al. (9) ascribed a unique role to TRb2 in negative regulation by T 3 when they showed hTRb2 to be much more efficient than hTRb1 in ligand-dependent repression of transcription from the hTRH promoter introduced into CV1 cells. This finding differs from our present data showing the two mouse isoforms to be equipotent in repressing ligand-dependent TRH transcription in the mouse hypothalamus in vivo. Clearly, the relative contributions of these isoforms need more detailed analysis.
Expression of TRa in the hypothalamus abolishes the negative feedback effect of T 3 on TRH transcription
There is consensus across the literature regarding the distinct actions of TRa1 vs. TRb on TRH transcription, specifically, the lack of T 3 -dependent regulation of TRH in the presence of the TRa isoform (6, 8) . These observations are particularly intriguing given that in each experiment a ligand binding form of TRa was used, and yet no change in transcriptional activation of the TRH promoter was seen in the presence or absence of ligand ( Fig. 3B; refs 6, 8 ). Yet we know from our experiments that ligand-dependent transcriptional modification can be elicited, as T 3 -dependent activation results from TRa coexpressed with the TRE construct (Fig. 4) . Many of the differential effects of TRa vs. TRb can be attributed to their distinct amino termini (7) . Although the amino termini of mouse and chicken TRa1 are different (65% isology), we found that both mTRa1 and cTRa1 had similar effects in this respect: expression of either one blocked T 3 -dependent repression of TRH transcription. However, the effects of these two TRas on basal levels of TRH-luc transcription were opposite, mTRa1 and cTRa1 respectively lowering and raising TRH transcription. This result was somewhat unexpected given the high conservation of sequence between the two isoforms (90% isology overall). Aligment of the two sequences shows a few conservative changes in the first 30 amino acids of the amino terminal and in the hinge region behind the DNA binding domain. It is possible that these conservative changes are sufficient to produce distinct interactions with the transcriptional machinery. Indeed, a 10 amino sequence (amino acids 21 to 30) in the amino terminal of the cTRa has been shown to be essential for an interaction between the TR and TFIIB (29) . Given the complexity of the interactions of TR with the transcriptional machinery and accessory proteins such as coactivators (for review, see ref 2) or corepressors (3) and that TRs show developmental and spatial regulations, it will be interesting to see whether exploring TR action in vivo will produce a better definition of / 383c de15 Mp 1763 Thursday Oct 22 08:58 AM LP-FASEB de15 the respective roles of receptor subtypes in modulating target gene transcription.
TR effects on TRH-luc transcription have correlated repercussions on thyroidal status
A final, striking observation resulting from these studies is that modulating TR expression in the hypothalamus results in correlated changes in thyroid hormone production. Indeed, expressing cTR increased basal transcription from the TRH promoter by sixfold and the effect on the HHT axis was a fourfold increase in circulating T 4 at P4. In contrast, expression of mTRa1 halved both TRH-luc transcription and T 4 secretion. Thus, there would appear to be a direct link between the effects of the different receptor subtypes on basal levels of transcription from the exogenous TRH promoter and their effects on endogenous TRH gene (as deduced from modulation of the HHT axis end point: T 4 production). No effect on circulating T 3 was seen. This is probably because most T 3 is not produced in the thyroid, but from peripheral deiodination (24) . No doubt, the changes in T 4 production produced by modulation of TR expression can be compensated for by changes in deiodination activity in the target tissues, thereby maintaining an euthyroid T 3 status overall.
In conclusion, our results confirm that the restricted expression of TRb2 correlates with its action in mediating negative feedback effects of thyroid hormone on TRH transcription. Moreover, misexpression of TRa1 in the hypothalamus results in up or down-regulation of TRH transcription according to the species origin of the TRa1 used, with alterations in TRH transcription played out down the HHT axis. Finally, this versatile methodology opens up new possibilites for dissecting the physiological relevance of transcription factor function in integrated contexts.
